Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia.

Schlachetzki JC, Fiebich BL, Haake E, de Oliveira AC, Candelario-Jalil E, Heneka MT, Hüll M.

J Neuroinflammation. 2010 Jan 11;7:2. doi: 10.1186/1742-2094-7-2.

2.

New therapeutic strategies for treatment of neurodegenerative diseases.

Kazantsev AG.

Curr Pharm Des. 2009;15(34):3917-8. No abstract available.

PMID:
20044916
3.

Mood, memory and movement: an age-related neurodegenerative complex?

Granholm AC, Boger H, Emborg ME.

Curr Aging Sci. 2008 Jul;1(2):133-9. Review.

4.

Neuroanatomy and pathology of sporadic Parkinson's disease.

Braak H, Del Tredici K.

Adv Anat Embryol Cell Biol. 2009;201:1-119. Review.

PMID:
19230552
5.

Peripheral lipopolysaccharide administration affects the olfactory dopamine system in mice.

Ota A, Mori K, Kaneko YS, Nakashima A, Nagatsu I, Nagatsu T.

Ann N Y Acad Sci. 2008 Dec;1148:127-35. doi: 10.1196/annals.1410.071.

PMID:
19120100
6.

Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice.

Boger HA, Middaugh LD, Granholm AC, McGinty JF.

Neurobiol Dis. 2009 Mar;33(3):459-66. doi: 10.1016/j.nbd.2008.11.013. Epub 2008 Dec 9.

7.

Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.

Kazantsev AG, Kolchinsky AM.

Arch Neurol. 2008 Dec;65(12):1577-81. doi: 10.1001/archneur.65.12.1577. Review.

PMID:
19064744
8.

The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior.

Zaman V, Boger HA, Granholm AC, Rohrer B, Moore A, Buhusi M, Gerhardt GA, Hoffer BJ, Middaugh LD.

Eur J Neurosci. 2008 Oct;28(8):1557-68. doi: 10.1111/j.1460-9568.2008.06456.x.

9.

Immunological features of alpha-synuclein in Parkinson's disease.

Roodveldt C, Christodoulou J, Dobson CM.

J Cell Mol Med. 2008 Oct;12(5B):1820-9. doi: 10.1111/j.1582-4934.2008.00450.x. Epub 2008 Jul 30. Review. Erratum in: J Cell Mol Med. 2008 Dec;12(6B):2875.

10.

Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits.

Liu Y, Qin L, Wilson B, Wu X, Qian L, Granholm AC, Crews FT, Hong JS.

Neurotoxicology. 2008 Sep;29(5):864-70. doi: 10.1016/j.neuro.2008.02.014. Epub 2008 Mar 13.

11.

High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice.

Thirumangalakudi L, Prakasam A, Zhang R, Bimonte-Nelson H, Sambamurti K, Kindy MS, Bhat NR.

J Neurochem. 2008 Jul;106(1):475-85. doi: 10.1111/j.1471-4159.2008.05415.x. Epub 2008 Jul 1.

12.

Parkinson's disease: a dual-hit hypothesis.

Hawkes CH, Del Tredici K, Braak H.

Neuropathol Appl Neurobiol. 2007 Dec;33(6):599-614. Epub 2007 Oct 24. Review.

PMID:
17961138
13.

The effects of maternal inflammation on neuronal development: possible mechanisms.

Jonakait GM.

Int J Dev Neurosci. 2007 Nov;25(7):415-25. Epub 2007 Sep 14. Review.

PMID:
17949937
15.

Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice.

Boger HA, Middaugh LD, Patrick KS, Ramamoorthy S, Denehy ED, Zhu H, Pacchioni AM, Granholm AC, McGinty JF.

J Neurosci. 2007 Aug 15;27(33):8816-25.

16.

Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease.

Wahner AD, Sinsheimer JS, Bronstein JM, Ritz B.

Arch Neurol. 2007 Jun;64(6):836-40.

PMID:
17562931
17.

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter.

Manning-Boğ AB, Caudle WM, Perez XA, Reaney SH, Paletzki R, Isla MZ, Chou VP, McCormack AL, Miller GW, Langston JW, Gerfen CR, Dimonte DA.

Neurobiol Dis. 2007 Aug;27(2):141-50. Epub 2007 May 3.

PMID:
17560790
18.
19.

Model fusion, the next phase in developing animal models for Parkinson's disease.

Manning-Bog AB, Langston JW.

Neurotox Res. 2007 Apr;11(3-4):219-40. Review.

PMID:
17449461
20.

The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder.

Barlow BK, Cory-Slechta DA, Richfield EK, Thiruchelvam M.

Reprod Toxicol. 2007 Apr-May;23(3):457-70. Epub 2007 Feb 6. Review.

PMID:
17350799

Supplemental Content

Support Center